Investment and M&A transaction comps

Beauty Brand Investment & M&A Transaction Comps

Beauty, personal care, cosmetics, skin care, hair care and related brand transactions.

26
Reviewed transactions
22
With price data
4.6x
Median EV or valuation / revenue
17.8x
Median EV or valuation / EBITDA
Year Transactions Priced Median EV or valuation / revenue Median EV or valuation / EBITDA
2024 3 3 3.8x 10.6x
2023 6 6 4.2x 22.0x
2022 3 2 4.9x 21.4x
2021 7 6 4.7x 15.3x
2020 3 2 5.7x 13.3x

Sortable transaction comps

Beauty transaction table

Filter transactions

Narrow the table without crowding the main view.

Clear all filters

Rows with reported value

22 / 25

Acquisition value, USD

USD 14B

Investment capital, USD

USD 84.0M

Median EV or valuation / revenue

4.6x

Columns

Show columns

Select up to 12 rows across filters and pages, then share or export the set.

25 shown of 26 matching transactions. Click any transaction row for more detail.

Select for comparison
Saltair
Control
2026-07-30 TSG Consumer 458 4.6x 15.3x
BeautyConsumer
+3
Personal CareSkin CareBody Care
Beautynova
Control
2024-03-18 PAI Partners 365 2.5x 10.6x
Hair CareBeauty & Personal Care
+2
CPGGrooming
ChapStick
Control
2024-01-25 Suave Brands Company 510 - -
BeautyConsumer
+3
Personal CareLip BalmLip Care
2024-01-01 Puig 354 5.0x -
BeautyBody Care
+4
CPGHaircarePremium SkincareSkincare
Go-To Skincare
Control
2023-12-15 Zoë Foster Blake 15 - -
BeautyCPG
+1
Skincare
Straand
Capital Raise
2023-12-10 Unilever Ventures 4 - -
Hair CareCPG
+1
Scalp Care
COSRX
Control (38%)
2023-10-30 Amorepacific 1,000 3.6x -
CosmeticsCPG
+2
K BeautySkincare
Naturium
Control
2023-08-29 Elf 354 3.9x 20.9x
BeautyConsumer
+2
Beauty / SkincareSkincare
Aesop
Control
2023-04-03 L’Oréal 2,500 4.4x 24.7x
CosmeticsBeauty / Skincare
+4
Personal CareCPGLuxury BeautySkincare
Mielle Organics
Control
2023-01-11 P&G Beauty 639 5.6x 22.0x
BeautyHair Care
+6
CPGPersonal CareHaircareNatural HaircarePersonal Care HaircareTextured Hair Care
Nutrafol
Control
2022-05-30 Unilever Undisclosed 4.9x 22.7x
BeautyPersonal Care
+4
CPGHair Growth ProductsHair WellnessPersonal Care Hair Wellness
NAK Hair
Control
2022-05-01 Adamantem Capital 65 2.3x -
Hair CareCPG
+1
Salon Haircare
Ilia Beauty
Control
2022-02-01 Courtin-Clarins family / Clarins 689 7.0x 20.0x
CosmeticsBeauty And Cosmetics
+4
Clean BeautyCPGMakeupSkincare
Chantecaille
Control
2021-12-21 Beiersdorf 688 4.6x 15.3x
CosmeticsCPG
+3
Prestige BeautyPrestige Beauty / SkincareSkincare
E45
Control
2021-12-01 Karo Healthcare Undisclosed 4.7x -
ConsumerSkin Care
+3
DermocosmeticsDry Skin TreatmentPersonal Care / Skin Care & Dermocosmetics
Sol de Janeiro
Control (83%)
2021-11-15 L'Occitane 450 7.5x 21.1x
BeautyConsumer
+6
Body CareHair CareCPGFragrancePersonal Care And BeautyPremium Beauty
Obagi
Control
2021-11-15 Waldencast 865 4.5x 17.2x
BeautyClinical Skincare
+2
CPGSkincare
Milk Makeup
Control
2021-11-15 Waldencast Acquisition Corp. 386 5.8x -
BeautyBeauty & Personal Care
+3
Color CosmeticsCPGMakeup
Vegamour
Minority
2021-04-13 General Atlantic 80 3.0x 15.0x
Hair CareCPG
+4
Hair Growth ProductsHair WellnessPersonal Care / Hair Wellness And GrowthVegan Beauty
Go-To Skincare
Control (50%)
2021-03-01 BWX 138 4.8x 14.9x
BeautyCPG
+1
Skincare
Every Man Jack
Control
2020-12-01 The Carlyle Group Undisclosed - -
ConsumerHair Care
+5
Personal CareDeodorantSkin CareMen'S GroomingShaving
Cremo
Control
2020-08-04 Edgewell Personal Care 235 4.1x -
Personal CareBeard Care
+4
CPGMen'S GroomingPersonal Care And GroomingShaving
2020-06-18 L'Oréal 400 7.3x 13.3x
Personal CareCPG
+2
Natural SkincarePersonal Care / Natural Skincare
Filorga
Control
2019-07-11 Colgate-Palmolive 1,690 8.3x -
CosmeticsAnti Aging Skincare
+6
Beauty & Personal CareCPGPersonal Care SkincarePremium BeautyPrestige SkincareSkincare
2018-10-23 Johnson & Johnson 2,100 4.5x 22.0x
BeautyCPG
+1
Skincare
FundComb transaction comps are informational only. Prices are shown as estimated enterprise value where available, with USD used as the default sorting currency; revenue and EBITDA multiples are shown where available. Values may be estimated, rumored, incomplete or derived from public information and should not be relied upon as financial, investment or valuation advice.